A carregar...
Interplay between Hepatitis C Virus and Redox Cell Signaling
Hepatitis C virus (HCV) infects approximately 3% of the world’s population. Currently licensed treatment of HCV chronic infection with pegylated-interferon-α and ribavirin, is not fully effective against all HCV genotypes and is associated to severe side effects. Thus, development of novel therapeut...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Molecular Diversity Preservation International (MDPI)
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3634496/ https://ncbi.nlm.nih.gov/pubmed/23443167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms14034705 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|